AI and machine learning in drug development​

Artificial intelligence (AI) and machine learning are rapidly transforming drug development—but what opportunities exist specifically in drug formulation?​

Artificial intelligence (AI) is rapidly transforming drug development—but what opportunities exist specifically in drug formulation? During this digital event, you will receive an up-to-date introduction to the field as well as concrete examples of how AI and machine learning are already being used in drug research and development.

Program

16.00 – 17.30  Lecture with Lars Tornberg, Associate Principal Scientist, Predictive Science, AstraZeneca och Anne Juppo, Professor, University of Helsinki.

Target audience

People in academia and industry with an interest in AI and drug development and drug formulation.

Time & Place

October 6, 2026.
At 16.00 – 17.30.

This is an online event that will take place on Zoom.

A warm welcome wishes the Section for Drug Formulation!